Read the latest newsletter from the JDRF of North Central CT and Western MA. Dr. Kevan Herold's study on the effects of exenatide (also known as Bydureon) on Type 1 diabetes is featured. Click here to read the newsletter and for a link to the JDRF chapter website for more information on Type 1 diabetes.
Submitted by Lisa Brophy on January 27, 2014